Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.01B
sum of reported positions
Reported positions
489
Changes vs prior quarter
492
132 new · 79 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 155 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.45M | $691M | 8.6% | |
TEVA PHARMACEUTICAL INDS LTD | 12.5M | $412M | 5.1% |
| 1.37M | $397M | 5.0% | |
| 1.1M | $394M | 4.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.52B | $8.01B |
| Positions | 436 | 489 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 9% |
| 1.95M |
| $391M |
| 4.9% |
| 1.63M | $389M | 4.9% |
| 484K | $367M | 4.6% |
| 3.91M | $345M | 4.3% |
| 1.94M | $228M | 2.8% |
| 590K | $209M | 2.6% |
| 1.17M | $171M | 2.1% |
| 1.8M | $164M | 2.1% |
| 2.24M | $161M | 2.0% |
| 390K | $155M | 1.9% |
| 2.65M | $151M | 1.9% |
| 519K | $146M | 1.8% |
| 757K | $140M | 1.7% |
| 1.63M | $135M | 1.7% |
| 1.34M | $128M | 1.6% |
| 1.41M | $123M | 1.5% |
| 1.14M | $121M | 1.5% |
| 24M | $120M | 1.5% |
| 360K | $118M | 1.5% |
| 667K | $113M | 1.4% |
| 610K | $99.8M | 1.2% |
Argan, Inc. (AGX)
7,079 shares in Q1 2026
PayPal (PYPL) · CALL
7,000 shares in Q1 2026
ITRON INC
5,509 shares in Q1 2026
TEVA PHARMACEUTICAL INDS LTD · CALL
4,780 shares in Q1 2026
MICROSOFT CORP · CALL
3,600 shares in Q1 2026
CNH Industrial (CNH)
3,488 shares in Q1 2026
Lowe's (LOW)
3,347 shares in Q1 2026
Taiwan Semiconductor Manufacturing (TSM) · CALL
3,000 shares in Q1 2026
Nike (NKE)
2,990 shares in Q1 2026
Nuscale Power (SMR)
2,594 shares in Q1 2026
AES Corporation (AES)
2,417 shares in Q1 2026
NOV Inc. (NOV)
2,030 shares in Q1 2026
Conagra Brands (CAG)
1,931 shares in Q1 2026
Albertsons (ACI)
1,847 shares in Q1 2026
Smithfield Foods (SFD)
1,524 shares in Q1 2026
Annaly Capital Management (NLY)
1,452 shares in Q1 2026
ARTELO BIOSCIENCES INC
889 shares in Q1 2026
CarMax, Inc. (KMX)
849 shares in Q1 2026
Taiwan Semiconductor Manufacturing (TSM) · PUT
778 shares in Q1 2026
Nebius Group (NBIS) · CALL
683 shares in Q1 2026
Millicom International Cellular (TIGO)
633 shares in Q1 2026
Eastman Chemical Company (EMN)
538 shares in Q1 2026
Delta Air Lines (DAL)
491 shares in Q1 2026
CF Industries (CF)
418 shares in Q1 2026
Global Payments (GPN)
414 shares in Q1 2026